$140 Million Verdict in AndroGel Testosterone Case
A federal jury in Chicago has ordered the pharmaceutical company AbbVie Inc. to pay a Tennessee man more than $140 million as compensation for a heart attack he claimed was caused by his taking testosterone-replacement drug AndroGel.
October 09, 2017 at 05:24 PM
5 minute read
Northern District of Illinois at Dirksen Federal Building (foreground) in downtown Chicago. |
A federal jury in Chicago has ordered the pharmaceutical company AbbVie Inc. to pay a Tennessee man more than $140 million as compensation for a heart attack he claimed was caused by his taking the testosterone-replacement drug AndroGel.
The Oct. 5 verdict, first reported by Reuters, was delivered after a mistrial was declared in June when one of plaintiff Jeffrey Konrad's lead attorneys became ill.
The pharmaceutical company said it planned to appeal. Another of Konrad's lawyers, David Buchanan of the New York office of Seeger Weiss, could not be reached for comment Monday.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 4What We Know About the Kentucky Judge Killed in His Chambers
- 5'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
